Tumor mutation burden testing: a survey of the International Quality Network for Pathology (IQN Path)

Fenizia F, Wolstenholme N, Fairley JA, Rouleau E, Cheetham MH, Horan MP, Torlakovic E, Besse B, Al Dieri R, Tiniakos DG, Deans ZC, Patton SJ, Normanno N. Tumor mutation burden testing: a survey of the International Quality Network for Pathology (IQN Path). Virchows Arch. 2021 Apr 15. doi: 10.1007/s00428-021-03093-7. Epub ahead of print. PMID: 33856555.

HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusions.

Bruford, E.A., Antonescu, C.R., Carroll, A.J. et al. HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusions. Leukemia (2021). https://doi.org/10.1038/s41375-021-01436-6

Biomarker testing in oncology - Requirements for organizing external quality assessment programs to improve the performance of laboratory testing: revision of an expert opinion paper on behalf of IQNPath ABSL.

Dufraing K, Fenizia F, Torlakovic E, Wolstenholme N, Deans ZC, Rouleau E, Vyberg M, Parry S, Schuuring E, Dequeker EMC; IQNPath ABSL. Virchows Arch. 2021 Mar;478(3):553-565. doi: 10.1007/s00428-020-02928-z. Epub 2020 Oct 13. PMID: 33047156; PMCID: PMC7550230.

Chromosomes in the Genomic Age. Preserving Cytogenomic Competence of Diagnostic Genome Laboratories.

Hochstenbach R, Liehr T, Hastings RJ. Eur J Hum Genet. 2021 Apr;29(4):541-552. doi: 10.1038/s41431-020-00780-y. Epub 2020 Dec 11. PMID: 33311710; PMCID: PMC8115145.

Opportunistic genomic screening. Recommendations of the European Society of Human Genetics.

de Wert G, Dondorp W, Clarke A, Dequeker EMC, Cordier C, Deans Z, van El CG, Fellmann F, Hastings R, Hentze S, Howard H, Macek M, Mendes A, Patch C, Rial-Sebbag E, Stefansdottir V, Cornel MC, Forzano F; European Society of Human Genetics. Eur J Hum Genet. 2021 Mar;29(3):365-377. doi: 10.1038/s41431-020-00758-w. Epub 2020 Nov 22. PMID: 33223530; PMCID: PMC7940405.